Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS).
Benhaim L, Bouché O, Normand C, Didelot A, Mulot C, Le Corre D, Garrigou S, Djadi-Prat J, Wang-Renault SF, Perez-Toralla K, Pekin D, Poulet G, Landi B, Taieb J, Selvy M, Emile JF, Lecomte T, Blons H, Chatellier G, Link DR, Taly V, Laurent-Puig P.
Benhaim L, et al. Among authors: landi b.
Eur J Cancer. 2021 Dec;159:24-33. doi: 10.1016/j.ejca.2021.09.004. Epub 2021 Oct 30.
Eur J Cancer. 2021.
PMID: 34731746